CSIMarket
 

Eyepoint Pharmaceuticals Inc   (EYPT)
Other Ticker:  
 

Eyepoint Pharmaceuticals Inc 's Working Capital Per Sales

EYPT's Working Capital and Revenue growth



EYPT Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change -45.35 % -43.06 % -36.69 % -35.41 % 29.55 %
Y / Y Revenue Change 51.84 % -21.27 % -17.33 % -8.76 % 10.52 %
Working Capital Per Revenue 2.6 3.44 3.69 3.96 4.31
Total Ranking # 2838 # 2840 # 2193 # 142 # 1896
Seq. Working Capital Change -12.15 % -17.35 % -14.07 % -12.4 % -8.48 %
Seq. Revenue Change 66.96 % 18.51 % -27.06 % 5.2 % -13.43 %





Comment on EYPT's Working Capital Per Revenue in the third quarter 2023
Eyepoint Pharmaceuticals Inc 's Working Capital Per Revenue in the Q3 2023 sequentially fell to 2.6 below the company average.

Within Healthcare sector 82 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Eyepoint Pharmaceuticals Inc Working Capital Per Revenue overall ranking has impoved so far in the Q3 2023 to 2838, from total ranking in the second quarter 2023 at 2840.
Working Capital Per Revenue Ranking
Within: No.
Industry # 3
Sector # 83
S&P 500 # 2838


Working Capital Per Revenue Statistics
High Average Low
17.29
4.83
0.81
(Dec 31 2018)   (Sep. 30, 2014)



Financial Statements
Eyepoint Pharmaceuticals Inc 's Working Capital $ 86 Millions Visit EYPT's Balance sheet
Eyepoint Pharmaceuticals Inc 's Revenues $ 15 Millions Visit EYPT's Income Statement
Where are EYPT's Sales coming from? Visit EYPT's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Dermtech Inc   7.07 
Hcw Biologics Inc   7.01 
Innovative Eyewear Inc   6.90 
Aclaris Therapeutics Inc   6.78 
Arcus Biosciences Inc   6.68 
Delcath Systems Inc   6.64 
Curis Inc   6.61 
Arcutis Biotherapeutics Inc   6.33 
Bluebird Bio Inc   6.30 
Nighthawk Biosciences inc   6.29 
Marinus Pharmaceuticals Inc   6.13 
Somalogic Inc   6.11 
Sutro Biopharma Inc   6.08 
Rewalk Robotics Ltd   6.03 
Aadi Bioscience Inc   5.94 
Maxcyte inc   5.83 
Alector Inc   5.69 
Arbutus Biopharma Corp  5.62 
Zevra Therapeutics Inc   5.59 
Inspiremd Inc   5.59 
Rapid Micro Biosystems Inc   5.51 
Zomedica Corp   5.42 
Merus N v   5.30 
Cara Therapeutics inc   5.28 
Hookipa Pharma inc   5.21 
Orchard Therapeutics Plc  5.14 
Mersana Therapeutics Inc   5.08 
Alpine Immune Sciences Inc   5.07 
Werewolf Therapeutics Inc   4.94 
Arvinas Inc   4.90 
Date modified: 2023-11-04T20:00:45+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com